ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1426	National Cancer Institute	Html	en	Childhood Ependymoma Treatment (PDQ®)–Health Professional Version	In childhood ependymoma, cancer forms in the tissues of the brain and spinal cord. The cause of ependymoma is unknown. Find out about the molecular and clinical features, diagnosis, prognosis, treatment, and clinical trials for pediatric ependymoma, subependymoma, myxopapillary ependymoma, anaplastic ependymoma, and RELA fusion–positive ependymoma.	childhood recurrent ependymoma 0.446141 Merchant TE 0.374501 Brain Tumor Registry 0.351132 childhood brain tumor 0.35242 spinal cord ependymomas 0.479172 nervous system ependymoma 0.395153 posterior fossa ependymoma 0.628195 brain tumors 0.516421 children 0.409198 malignant brain tumors 0.384396 newly diagnosed ependymoma 0.411931 Sayegh ET 0.377382 Int J Radiat 0.476989 Radiat Oncol Biol 0.6983 World Health Organization 0.41477 intracranial ependymoma recurrence 0.508211 pediatric supratentorial tumors 0.369961 posterior fossa tumors 0.3562 infratentorial ependymoma 0.423041 ependymoma patients 0.42421 intracranial ependymomas 0.39986 Supratentorial ependymoma 0.435338 Clin Cancer Res 0.386576 paediatric ependymoma 0.450128 pediatric intracranial ependymoma 0.570833	radiation therapy 0.449829 Acta Neuropathol 0.35243 et al. 0.743726 childhood ependymoma 0.513088 intracranial ependymoma 0.927373 recurrent ependymoma 0.45402 Neuro Oncol 0.356088 primary brain tumors 0.39985 pediatric intracranial ependymomas 0.371298 adult ependymoma cases 0.44321 Pediatr Blood Cancer 0.534048 childhood ependymomas 0.358916 Metastatic ependymoma 0.401089 posterior fossa ependymomas 0.381573 spinal cord 0.504643 Abstract 0.696 non-anaplastic ependymoma 0.396839 childhood intracranial ependymoma 0.687299 Clin Oncol 0.484182 childhood brain tumors 0.3515 Oncol Biol Phys 0.714533 spinal canal ependymoma 0.421296 Central Brain Tumor 0.351707 Childs Nerv Syst 0.489135	CLICK HERE
1558	National Cancer Institute	Html	en	Endometrial Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing endometrial cancer and about research aimed at the prevention of this disease.	cancer treatment 0.459672 cancer prevention trials 0.519855 estrogen 0.503683 endometrial cancer prevention 0.633127 protective factors 0.494311 following PDQ summaries 0.487054 PDQ cancer information 0.583616 estrogen receptor modulators 0.479388 oral contraceptives increases 0.455046 uterus 0.455824 clinical trials 0.591442 cancer information summary 0.536389 breast cancer prevention 0.515055 cancer patients 0.456862 cancer risk factor 0.514935 NCI’s PDQ 0.460213 metabolic syndrome 0.469608 Clinical Trials section 0.455747 NCI PDQ cancer 0.511939 endometrial hyperplasia 0.525569 hormone replacement therapy 0.4814 new cases 0.45495 estrogen levels 0.496361 cancer risk factors 0.513284	Cancer prevention 0.648371 cancer protective factor 0.491722 high estrogen levels 0.479463 Cancer Information Service 0.48404 polycystic ovary syndrome 0.484739 prevention clinical trials 0.493334 Prevention Editorial Board 0.485326 treatment clinical trials 0.456257 National Cancer Institute 0.542099 endometrial cancer 0.951484 African American women 0.525683 estrogen therapy 0.459908 higher risk 0.454955 postmenopausal women 0.557323 Cancer Care page 0.476271 PDQ database 0.456704 PDQ summary 0.495085 combination oral contraceptives 0.477913 cancer clinical trials 0.489805 risk factors 0.587492 nonpolyposis colon cancer 0.481746 cancer information summaries 0.48866 comprehensive cancer information 0.488387 risk 0.63452	CLICK HERE
1881	National Cancer Institute	Html	es	Tratamiento del sarcoma de Ewing (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del Sarcoma de Ewing.	ewing sarcoma 0.997403 Ewing family 0.318421 Ewing's sarcoma family 0.369762 metastatic ewing sarcoma 0.318472 ewing óseo valor 0.311245 skeletal localized ewing 0.310397 Ewing Grupo 0.309837 non-metastatic ewing 0.310313 Ewing's Sarcoma Studies 0.319442 ewing óseo característica 0.311302 Ewing extraóseo 0.331665 Ewing sarcoma demonstrates 0.319966 Ewing sarcoma with 0.320002 localized ewing tumours 0.310538 localized ewing 0.369471 ewing-like sarcomas 0.313809 Children's Oncology Group 0.332597 ewing sarcoma family 0.424972 Ewing sarcoma patients 0.320654 with ewing 0.35586 Ewing's tumors with 0.311931 Ewing Sarcoma Study 0.321953 with localized ewing 0.320841 primary ewing 0.310256 extraskeletal ewing sarcoma 0.318994	Ewing's Sarcoma Study 0.335323 synovial sarcoma 0.309759 cooperative ewing sarcoma 0.431437 Ewing sarcoma under 0.319395 EWSR1-rearranged Ewing 0.309748 localized ewing tumor 0.320103 ewing extraóseo sarcoma 0.320923 osseous ewing 0.30998 Pediatr Blood Cancer 0.363663 ewing sarcoma defines 0.332159 Intergroup Cooperative Ewing 0.343374 Ewing Sarcoma Studies 0.337882 Genes Chromosomes Cancer 0.320148 ewing's sarcoma 0.626467 Ewing óseo 0.324425 gen ewsr1 0.309831 ewing's tumors 0.326472 secondary ewing 0.310067 Pediatr Hematol Oncol 0.310262 Clin Oncol 0.365031 multifocal ewing sarcoma 0.318953 ewing tumors 0.399514 congenital ewing sarcoma 0.318921 Ewing sarcoma susceptibility 0.318556	CLICK HERE
1942	National Cancer Institute	Html	es	Tratamiento de las neoplasias mielodisplásicas o mieloproliferativas (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de las neoplasias mielodisplásicas o mieloproliferativas, incluso las leucemias mielomonocítica crónica o juvenil y la LMC atípica.	French-American-British Cooperative Leukaemia 0.312371 leucemia mieloide 0.341853 myelomonocytic leukaemia 0.397359 myelomonocytic leukemia with 0.326213 platelet-derived growth factor 0.354049 with juvenile chronic 0.315892 Arber DA 0.312178 health organization classification 0.3281 Leukemia Group 0.315441 genes platelet-derived growth 0.312347 with juvenile 0.340061 chronic myeloid leukemia 0.336615 myelomonocytic leukemia 0.944712 leucemia mielomonocítica 0.387953 chronic myelomonocytic leukemia 0.819447 differentiating myelomonocytic leukemia 0.320578 Beran M 0.312167 World Health Organization 0.355665 neoplasias mielodisplásicas 0.314258 stem cell transplantation 0.313202 chronic myelogenous leukemia 0.364294 Germing U 0.362762 myeloproliferative disorders 0.313394 cases with chronic 0.311538 Leuk Lymphoma 0.332534	myelomonocytic leukemia from 0.33992 chronic myelomonocytic leukaemia 0.386185 juvenile chronic myelogenous 0.347073 marrow transplantation 0.341155 Organización Mundial 0.317633 chronic myeloid 0.357031 Differentiating juvenile myelomonocytic 0.319715 myeloid neoplasms 0.336696 bone marrow transplantation 0.325127 Bennett JM 0.319603 cromosoma filadelfia 0.337822 recuento plaquetario 0.325577 juvenile myelomonocytic leukaemia 0.339361 juvenile myelomonocytic leukemia 0.545157 chronic myeloid leukaemias 0.320258 Clin Oncol 0.32115 Orazi A 0.343564 Cooperative Leukaemia Group 0.311788 atypical chronic 0.319445 características clínicas 0.316309 trastornos mieloides 0.311632 leucemia mieloide aguda 0.316238 with chronic myelomonocytic 0.340508 Emanuel PD 0.350668	CLICK HERE
1946	National Cancer Institute	Html	es	Tratamiento del neuroblastoma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del neuroblastoma.	glándula tiroides 0.633074 posibles efectos tardíos 0.641796 siguientes procedimientos 0.632822 células madre 0.931788 gen alk 0.612181 siguientes especialistas 0.624871 yodo 131-mibg 0.744725 vía oral 0.649411 rayos x 0.630232 enlace drugs approved 0.631928 estadios 2A 0.624814 niño ayuda 0.632627 ondas sonoras 0.629873 riesgo intermedio 0.674697 efectos tardíos 0.896983 cáncer.ampliar aspiración 0.633221	National Cancer Institute 0.612675 IRMN).Ampliar Imágenes 0.62564 siguientes tratamientos 0.624353 menor producción 0.628805 Instituto Nacional 0.623964 PDQ Tratamiento 0.634123 determinados cambios 0.611022 alta potencia 0.625499 presente sección 0.614217 nuevos tipos 0.61878 sistema nervioso central 0.655496 Physician Data Query 0.650241 siguientes pruebas 0.680017 siguientes estadios 0.629707 siguientes trastornos 0.624626	CLICK HERE
1977	National Cancer Institute	Html	es	Tratamiento del carcinoma de corteza suprarrenal (PDQ®)–Versión para pacientes	Resumen de revisión revisada por expertos acerca del tratamiento del carcinoma de corteza suprarrenal.	siguientes procedimientos 0.496457 tinte circula 0.500083 pequeña cantidad 0.426407 estadio ii 0.722852 vía oral 0.42258 rayos x 0.485722 ondas sonoras 0.428325 National Cancer Institute 0.418399 sustancia llamada gadolinio 0.451231 suprarrenal elabora hormonas 0.951617 siguientes riesgos 0.416128 secciones cáncer 0.564083 Instituto Nacional 0.51582 PDQ Tratamiento 0.443801 siguientes hormonas 0.456613	presente sección 0.419609 corteza suprarrenal causa 0.829807 siguientes funciones 0.454626 Physician Data Query 0.471125 médula suprarrenal.Ampliar 0.44071 estadio iii 0.71977 características masculinas 0.438548 siguientes enfermedades 0.449744 PDQ Feocromocitoma 0.493816 suprarrenal causa efectos 0.739636 siguientes terapias 0.423482 PDQ Cánceres 0.484481 siguientes enlaces 0.420507 suprarrenal funcionante elabora 0.710246 siguientes pruebas 0.503631	CLICK HERE
2064	National Cancer Institute	Html	es	Exposición al asbesto y el riesgo de cáncer	Hoja informativa sobre el asbesto, sobre las enfermedades relacionadas con el asbesto e incluye organizaciones para obtener más información.	técnicos profesionales automotrices 0.5421 gen bap1 0.530949 que familiares de trabajadores 0.533144 normas descritas 0.532666 largo plazo 0.526581 Protección Ambiental 0.672505 World Trade Center 0.546459 principal dependencia 0.532045 Ground Zero 0.529197 derrames pleurales benignos 0.558277 Salud Ocupacional 0.584399 asbesto crisótilo 0.987156 trabajadores portuarios 0.606054 Instituto Nacional 0.563708 menores riesgos 0.533274 Trabajo de EE 0.535904 Employment Standards Administration 0.548898 titulado current best practices 0.543841 Mine Safety 0.535362 sustancias tóxicas 0.635631 siglo xix 0.53032 distintos tipos 0.525229 Estados Unidos 0.992615 automotriz usa 0.531695 Public Affairs 0.529764	serios problemas 0.529441 Environmental Protection Agency 0.815767 línea telefónica tsca 0.556811 Preventing Asbestos Exposure 0.544747 Product Safety Commission 0.67091 Information Division 0.52746 Occupational Safety 0.586355 asbesto causa 0.952053 cuánto tiempo 0.527545 en la mucosidad 0.531534 a las personas 0.529484 posibles peligros 0.5266 Health Administration 0.652906 Consumer Product Safety 0.672282 causa dificultad 0.530297 sumamente bajo. Los fabricantes 0.528798 mejores prácticas 0.574094 Clutch Repair Workers 0.544379 Veterans Affairs 0.528386 Torres Gemelas 0.52642 Compensation Programs 0.5287 Disease Registry 0.526245 Toxic Substances 0.526971 Segunda Guerra Mundial 0.550565	CLICK HERE
2071	National Cancer Institute	Html	es	Cirugía para reducir el riesgo de cáncer de seno	Hoja informativa que describe las clases de cirugía para reducir el riesgo de cáncer de seno y las situaciones en las que se puede pensar en esas operaciones.	Surgical Adjuvant Breast 0.526694 PROSE Study Group 0.516256 cáncer invasor 0.567762 brca1 or brca2 0.538495 mastectomía subcutánea 0.530865 Preventing breast 0.511838 Breast Cancer Research 0.523551 risk-reducing surgery 0.507962 with brca1 or 0.509298 brca2 mutation 0.564149 breast screening with 0.51472 Preventive Services Task 0.512338 mastectomy reduces breast 0.516804 alta penetrancia 0.508455 risk after smaller 0.509063 Friebel T 0.508008 PubMed Abstract 0.952028 Clinical Oncology 0.653359 Cancer Journal 0.515034 BRCA2 mutation carriers 0.554396 early breast cancer 0.539203 ¿Cuáles mujeres 0.517292 bilateral mastectomy 0.517477 BRCA2 mutations detected 0.508495 alto riesgo 0.656597	Wickerham DL 0.51571 an overview 0.508367 Costantino JP 0.515178 Cancer Risk Assessment 0.519342 Rebbeck TR 0.508232 developing invasive breast 0.513495 antecedentes familiares 0.554456 riesgo promedio 0.539499 or brca2 mutations 0.536318 breast cancer risk 0.617067 mutation carriers with 0.509322 gen pten 0.510383 breast cancer 0.801718 Breast Cancer Trialists 0.522907 Services Task Force 0.511925 prophylactic mastectomy 0.591377 mujeres portadoras 0.533011 gen brca1 0.561202 contralateral prophylactic mastectomy 0.534028 Cancer Institute 0.511805 Clinical Cancer Research 0.516971 gen brca2 0.561192 gen tp53 0.518098 New England Journal 0.535054	CLICK HERE
2988	National Cancer Institute	Html	en	Secondhand Smoke	Smoking affects both you and your loved one's health. Learn about the consequences of secondhand smoke and how you can protect your family.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
16645	National Cancer Institute	Html	en	Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment	An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.	cognitive problems 0.439925 cognitive behavioral therapy 0.339182 cancer treatment 0.685512 cognitive effects 0.256058 self-reported cognitive functioning 0.391696 lower cognitive performance 0.348528 cognitive decline 0.284161 chemotherapy 0.377855 long-term cognitive changes 0.331518 chemotherapy treatment 0.254041 cognitive challenges 0.286627 cognitive issues 0.282189 Kettering Cancer Center 0.246129 chemotherapy-associated cognitive impairment 0.369163 Wilmot Cancer Institute 0.218061 Dr. Ganz 0.536508 Jonsson Comprehensive Cancer 0.230946	Dr. Ahles 0.527642 cognitive rehabilitation program 0.323502 cognitive changes 0.469428 healthy women 0.234218 breast cancer patients 0.251612 recent research 0.354647 patients 0.34223 Cancer Therapy-Cognitive Function 0.218486 breast cancer survivors 0.783509 cognitive difficulties 0.366868 treatment-related cognitive impairment 0.464189 hormonal therapy 0.233078 self-reported cognitive complaints 0.381226 cognitive symptoms 0.25427 cognitive impairment 0.941275 neuropsychological tests 0.263188	CLICK HERE